FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (NIVAGEN PHARMACEUTICALS, INC.)

View source ↗

Summary

FDA approved the supplemental application for atorvastatin calcium from NIVAGEN Pharmaceuticals, Inc., authorizing the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Coronary Artery Disease
• Familial Hypercholesterolemia
• Hypercholesterolemia
• Hyperlipidemia
• Hypertriglyceridemia

Drugs mentioned

• ATORVASTATIN CALCIUM (atorvastatin calcium)

Snippet

SUPPL AP for ATORVASTATIN CALCIUM (ATORVASTATIN CALCIUM)